Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA1899 FangchinolineSummary: Fangchinoline has a wide range of biological activities such as immune-enhancing, anti-inflammatory and antiseptic, and anti-atherosclerotic. -
BA1900 DoravirineSummary: Doravirine (MK-1439) is a highly specific non-nucleoside reverse transcriptase inhibitor. -
BA1902 Ro24-7429Summary: Ro24-7429 is a potent and orally active HIV-1 trans-activator protein antagonist. -
BA1903 BRD-6929Summary: BRD-6929 is a class I histone deacetylase and brain permeability selective inhibitor. -
BA1904 MitoguazoneSummary: Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) is a synthetic polycarbony derivative with potent antitumor activity. -
BA1905 PF-3450074Summary: PF-3450074 (PF-74) is a specific inhibitor of the HIV-1 coat protein and exhibits broad-spectrum inhibition of isolates -
BA1906 DDX3-IN-2Summary: DDX3-IN-2 is an active DEADboxpolypeptide3 inhibitor with a value of 0.3 μM. -
BA1908 MS417Summary: MS417 is a selective inhibitor of BET-specific proteins. -
BA1909 GPI-1046Summary: GPI-1046, an immunoaffinity ligand without antibiotic effects, reduces ethanol intake by upregulating glutamate transporter protein 1 in the PFC and NAc core. -
BA1910 CyclotriazadisulfonamideSummary: Cyclotriazadisulfonamide (CADA) is a specifically targeted entry inhibitor.

